NASDAQ · GHRS
GH Research financials
$24.67+5.34%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross margin | — | — | — | — | — |
| Operating income | -$60.7M | -$50.3M | -$41.2M | -$30.6M | -$15.1M |
| Net income | -$48.3M | -$39.0M | -$35.6M | -$22.5M | -$9.2M |
| Net margin | — | — | — | — | — |
| Diluted EPS | $-0.79 | $-0.75 | $-0.68 | $-0.43 | $-0.21 |
| EBITDA | -$60.4M | -$50.0M | -$40.9M | -$30.5M | -$15.1M |
| Operating cash flow | -$43.6M | -$42.3M | -$33.3M | -$26.2M | -$15.3M |
| Free cash flow | -$43.7M | -$42.3M | -$33.4M | -$26.3M | -$15.4M |
| Diluted shares | 61.0M | 52.0M | 52.0M | 52.0M | 43.7M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|
| Cash & equivalents | $246.3M | $100.8M | $78.4M | $166.0M |
| Short-term investments | $34.5M | $29.1M | $27.5M | $0.00 |
| Total debt | $0.00 | $0.00 | $0.00 | $0.00 |
| Total assets | $288.2M | $188.3M | $226.3M | $254.4M |
| Total liabilities | $8.5M | $9.3M | $7.3M | $4.5M |
| Shareholders' equity | $279.7M | $179.0M | $219.0M | $249.8M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology